Cost-effectiveness of endovascular therapy for acute ischemic stroke with large infarct in China

医学 缺血性中风 冲程(发动机) 脑梗塞 心脏病学 外科 内科学 缺血 机械工程 工程类
作者
Yuesong Pan,Xiaochuan Huo,Aoming Jin,Thanh Ngoc Nguyen,Gaoting Ma,Xu Tong,Xuelei Zhang,Feng Gao,Ning Ma,Dapeng Mo,Zeguang Ren,Yongjun Wang,Zhongrong Miao
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:16 (5): 453-458 被引量:17
标识
DOI:10.1136/jnis-2023-020466
摘要

BACKGROUND: Endovascular therapy administered within 24 hours has been shown to improve outcomes for patients with acute ischemic stroke with large infarction, but the data on its cost-effectiveness are limited. OBJECTIVE: To evaluate the cost-effectiveness of endovascular therapy for acute ischemic stroke with large infarction in China, the largest low- and middle-income country. METHODS: A short-term decision tree model and a long-term Markov model were used to analyze the cost-effectiveness of endovascular therapy for patients with acute ischemic stroke with large infarction. Outcomes, transition probability, and cost data were obtained from a recent clinical trial and published literature. The benefit of endovascular therapy was assessed by the cost per quality-adjusted life-years (QALYs) gained in the short and long term. Deterministic one-way and probabilistic sensitivity analyses were performed to assess the robustness of the results. RESULTS: Compared with medical management alone, endovascular therapy for acute ischemic stroke with large infarction was found to be cost-effective from the fourth year onward and during a lifetime. In the long term, endovascular therapy yielded a lifetime gain of 1.33 QALYs at an additional cost of ¥73 900 (US$ 11 400), resulting in an incremental cost of ¥55 500 (US$ 8530) per QALY gained. Probabilistic sensitivity analysis showed that endovascular therapy was cost-effective in 99.5% of the simulation runs at a willingness-to-pay threshold of ¥243 000 (3 × gross domestic product per capita of China in 2021) per QALY gained. CONCLUSIONS: Endovascular therapy for acute ischemic stroke with large infarction could be cost-effective in China.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
汉堡包的应助被Nightt000采纳,获得10
1秒前
1秒前
childe发布了新的文献求助10
1秒前
莫小烦发布了新的文献求助10
1秒前
假装超人会飞完成签到,获得积分10
1秒前
haibo发布了新的文献求助10
2秒前
2秒前
gela发布了新的文献求助10
2秒前
完美世界的应助被fzy采纳,获得10
2秒前
3秒前
龙猫完成签到,获得积分10
3秒前
隐形曼青的应助被quanquan采纳,获得10
3秒前
3秒前
3秒前
4秒前
4秒前
kst发布了新的文献求助10
4秒前
拼搏的月亮完成签到,获得积分10
4秒前
WSZ完成签到,获得积分10
5秒前
5秒前
沉默之卉完成签到,获得积分10
6秒前
Lucas的应助被猪猪宝采纳,获得10
6秒前
职克琪发布了新的文献求助10
6秒前
jialin发布了新的文献求助10
7秒前
所所的应助被h11采纳,获得10
7秒前
高高亦竹完成签到,获得积分10
7秒前
7秒前
搜集达人的应助被云宇采纳,获得10
8秒前
Gaolongzhen完成签到 ,获得积分10
8秒前
科目三的应助被Jane采纳,获得10
8秒前
You完成签到,获得积分10
8秒前
QianQianONE发布了新的文献求助10
8秒前
9秒前
ZHAO发布了新的文献求助10
9秒前
JamesPei的应助被科研通管家采纳,获得10
10秒前
XING完成签到 ,获得积分10
10秒前
丘比特的应助被科研通管家采纳,获得10
10秒前
顾矜的应助被科研通管家采纳,获得40
10秒前
所所的应助被科研通管家采纳,获得10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8164445
求助须知:如何正确求助?哪些是违规求助? 9558283
关于积分的说明 21744871
捐赠科研通 7754979
什么是DOI,文献DOI怎么找? 3428582
关于科研通互助平台的介绍 2553119
邀请新用户注册赠送积分活动 2473142